Have a personal or library account? Click to login
Magnesium isoglycyrrhizinate protects against concanavalin A-induced immunological liver injury in a mouse model Cover

Magnesium isoglycyrrhizinate protects against concanavalin A-induced immunological liver injury in a mouse model

By: Zhengyan Jiang and  Liang Zheng  
Open Access
|Jul 2019

References

  1. 1. Zhou YX, Mo SL, Wang RH, Liu WF, Liu JC, Wang JQ, et al. Corn baked by burning coal triggered overexpression of osteopontin in hepatocytes of rats following fluorosis. Toxicol Ind Health. 2012;28(3):195-202. DOI: 10.1177/074823371141090510.1177/0748233711410905
  2. 2. Wang J, Zhao P, Guo H, Sun X, Jiang Z, Xu L, et al. Serum IL-33 levels are associated with liver damage in patients with chronic hepatitis C. Mediators Inflamm. 2012;2012:819636. DOI: 10.1155/2012/81963610.1155/2012/819636
  3. 3. Ingawale DK, Mandlik SK, Naik SR. Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): a critical discussion. Environ Toxicol Pharmacol. 2014;37(1):118-33. DOI: 10.1016/j.etap.2013.08.01510.1016/j.etap.2013.08.015
  4. 4. Rijckborst V, Sonneveld MJ, Janssen HL. Review article: chronic hepatitis B - anti-viral or immunomodula-tory therapy? Aliment Pharmacol Ther. 2011;33(5):501-13. DOI: 10.1111/j.1365-2036.2010.04555.x10.1111/j.1365-2036.2010.04555.x
  5. 5. de Groen RA, Boltjes A, Hou J, Liu BS, McPhee F, Friborg J, et al. IFN-λ-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells. Eur J Immunol. 2015;45(1):250-9. DOI: 10.1002/eji.20144490310.1002/eji.201444903
  6. 6. Yang Q, Zhao X, Zang L, Fang X, Zhao J, Yang X, et al. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice. Antiviral Res. 2012;96(3):333-9. DOI: 10.1016/j.antiviral.2012.10.00310.1016/j.antiviral.2012.10.003
  7. 7. Erhardt A, Biburger M, Papadopoulos T, Tiegs G. IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice. Hepatology. 2007;45(2):475-85. DOI: 10.1002/hep.2149810.1002/hep.21498
  8. 8. Xie C, Li X, Wu J, Liang Z, Deng F, Xie W, et al. Anti-inflammatory Activity of Magnesium Isoglycyrrhizinate Through Inhibition of Phospholipase A2/Arachidonic Acid Pathway. Inflammation. 2015;38(4):1639-48. DOI: 10.1007/s10753-015-0140-210.1007/s10753-015-0140-2
  9. 9. Tiegs G, Hentschel J, Wendel A. AT cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest. 1992;90(1):196-203. DOI: 10.1172/JCI11583610.1172/JCI115836
  10. 10. Gantner F, Leist M, Jilg S, Germann PG, Freudenberg MA, Tiegs G. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology. 1995;109(1):166-76. DOI: 10.1016/0016-5085(95)90282-110.1016/0016-5085(95)90282-1
  11. 11. Yu JJ, Zhang CS, Coyle ME, Du Y, Zhang AL, Guo X, et al. Compound glycyrrhizin plus conventional therapy for psoriasis vulgaris: a systematic review and meta-analysis of randomized controlled trials. Curr Med Res Opin. 2017;33(2):279-87. DOI: 10.1080/03007995.2016.125460510.1080/03007995.2016.125460527786567
  12. 12. van Rossum TGJ. In: Glycyrrhizin treatment for Chronic Hepatitis C. Erasmus University Rotterdam. 2000; retrieved from http://hdl.handle.net/1765/20441.
  13. 13. Wang HX, Liu M, Weng SY, Li JJ, Xie C, He HL, et al. Immune mechanisms of Concanavalin A model of autoimmune hepatitis. World J Gastroenterol. 2012;18(2):119-25. DOI: 10.3748/wjg.v18.i2.11910.3748/wjg.v18.i2.119325743822253517
  14. 14. Li WW, Yu JY, Xu HL, Bao JK. Concanavalin A: a potential anti-neoplastic agent targeting apoptosis, autophagy and anti-angiogenesis for cancer therapeutics. Biochem Biophys Res Commun. 2011;414(2):282-6. DOI: 10.1016/j.bbrc.2011.09.07210.1016/j.bbrc.2011.09.07221951850
  15. 15. Jakubowski A, Sternak M, Jablonski K, Ciszek-Lenda M, Marcinkiewicz J, Chlopicki S. 1-Methylnicotin-amide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α. Int Immunopharmacol. 2016;31:98-104. DOI: 10.1016/j.intimp.2015.11.03210.1016/j.intimp.2015.11.03226709075
  16. 16. Li J, Gong YM, Wu J, Wu WJ, Cai W. Anti-tumor necrosis factor-α monoclonal antibody alleviates parenteral nutrition-associated liver disease in mice. JPEN J Parenter Enteral Nutr. 2012;36(2):219-25. DOI: 10.1177/014860711142441210.1177/014860711142441222275328
  17. 17. Nicoletti F, Zaccone P, Xiang M, Magro G, Di Mauro M, Di Marco R, et al. Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein. Cytokine. 2000;12(4):315-23. DOI: 10.1006/cyto.1999.056110.1006/cyto.1999.056110805211
  18. 18. Capuron L, Geisler S, Kurz K, Leblhuber F, Sperner-Unterweger B, Fuchs D. Activated immune system and inflammation in healthy ageing: relevance for tryptophan and neopterin metabolism. Curr Pharm Des. 2014;20(38):6048-57. DOI: 10.2174/138161282066614031711021710.2174/138161282066614031711021724641220
  19. 19. Ceccarelli G, Brenchley JM, Cavallari EN, Scheri GC, Fratino M, Pinacchio C, et al. Impact of High-Dose Multi-Strain Probiotic Supplementation on Neurocognitive Performance and Central Nervous System Immune Activation of HIV-1 Infected Individuals. Nutrients. 2017;9(11):E1269. DOI: 10.3390/nu911126910.3390/nu9111269570774129160817
DOI: https://doi.org/10.2478/rrlm-2019-0026 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 281 - 290
Submitted on: Oct 15, 2018
|
Accepted on: Apr 11, 2019
|
Published on: Jul 30, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2019 Zhengyan Jiang, Liang Zheng, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.